Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn

American Journal of Perinatology

Volumn 13, Issue 6, 1996, Pages 335-342

  Kumar, Praveen ^a,b   Kazzi, Nadya J ^a   Shankaran, Seetha ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

extracorporeal membrane oxygenation; immunoreactive endothelin 1; Persistent pulmonary hypertension of the newborn

Indexed keywords

ENDOTHELIN 1;

ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; EXTRACORPOREAL OXYGENATION; FEMALE; GESTATIONAL AGE; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PULMONARY HYPERTENSION; RADIOIMMUNOASSAY;

EID: 0029820551     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994352     Document Type: Article

References (42)

1. Voelkel NF, Weir EK Etiologic mechanisms in primary pulmonary hypertension. In Weir EK, Reeves JT (eds): Pulmonary Vascular Physiology and Pathophysiology. New York: Marcel Dekker, 1989, pp 513-9
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature 1980;288:373-6
3. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEBJ 1989;3:2007-18
4. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides. thromboxane A2, and prostacyclin. Pharmacol Rev 1978;30:293-331
5. Griffith TM, Lewis MJ, Newby AC, Henderson AH. Endothelium derived relaxing factor. J Am Coll Cardiol 1988;12:797-806
6. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5
7. Ryan US, Glassberg MK, Nolop KB. Endothelin-1 from pulmonary artery and microvessels acts on vascular and airway smooth muscle. J Cardiovasc Pharmacol 1989; 13(suppl 5):S57-62
8. Ohtsuka M, Uchida Y, Saotome M, et al. Endothelin exerts to human pulmonary artery as a vasoconstrictor in vitro (Abstract). Am Rev Respir Dis 1989;139:A51
9. Lippton HL, Hauth TA, Summer WR, Hyman AL. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J Appl Phvsiol 1989;66:1008-12
10. Horgan MJ, Pinheiro JM, Malik AB. Mechanism of Endothelin-1 induced pulmonary vasoconstriction. Circ Res 1991;69:157-64
11. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease. Ann Intern Med 1991;114: 464-9
12. Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Circulation 1991,84:2280-5
13. Chang H, Wu GJ, Wang SM, Hung CR. Plasma endothelin levels and surgically correctable pulmonary hypertension. Ann Thorac Surg 1993;55:450-8
14. Rosenberg AA, Kennaugh J, Koppenhafer SL, et al. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993; 123:109-14
15. Levin ER Endothelins. N Engl J Med 1995;333.356-63
16. Wong J, Vanderford PA, Fineman JR, et al. Endothelin-1 produces potent pulmonary vasodilation in the intact newborn lamb. Am J Physiol 1993;265:H1318-H1325
17. Perreault T, De Marte J. Endothelin-1 has a dilator effect on neonatal pig pulmonary vasculature. J Cardiovasc Pharmacol 1991;18;43-50
18. Chatfield BA, McMurtry IF, Hall SL, Abman SH. Hemodynamic effects of endothelin-1 on ovine fetal pulmonary circulation. Am J Physiol 1991;261:R182-R187
19. Komuro I, Kurihara H, Sugiyama T, et al. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249-52
20. Dubin D, Pratt RE, Dzau VJ. Endothelin, a potent vasoconstrictor is a vascular smooth muscle mitogen. J Vas Med Biol 1989;1:150-4
21. Takuwa N, Takuwa Y, Yanagisawa M, et al. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 1989;264:7856-61
22. Muldoon LL, Rodland KD, Forsythe ML, Magun BE. Stimulation of phosphotidylmositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblast and smooth muscle cells. J Biol Chem 1989;264:8529-36
23. Cody RJ, Haas GJ, Binkley PF, et al. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9
24. Kumar P, Kazzi NJ, Shankaran S. Plasma immunoreactive endothelin-1 concentration in cord blood of normal term neonates. Am J Perinatol 1995;12:113-5
25. Stenmark KR, Abman SH, Accurso FJ. Etiologic mechanisms in persistent pulmonary hypertension of the newborn. In Weir EK, Reeves JT (eds): Pulmonary Vascular Physiology and Pathophysiology. New York: Marcel Dekker, 1988, pp 355-402
26. Murphy JD, Rabinovitch M, Golstein J, Reid LM. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 1981;98:962-7
27. Haworth SG. Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art. Chest 1988; 93:133S-8S
28. Bonvallet ST, Oka M, Yano M, et al. BQ123, an ETA receptor antagonist, attenuates endothelin -1 induced vasoconstriction in rat pulmonary circulation. J Cardiovasc Pharmacol 1993;22:39-43
29. White DG, Cannon TR, Garratt H, et al. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. J Cardiovasc Pharmacol 1993;22(suppl 8):S144-8
30. MacLean MR, McCulloch KM, Baird M. Endothelin ETA and ETB receptor mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol 1994;23: 838-45
31. Langleben D, Serban L, Blais D, et al. Hypoxia stimulates endothelm-1 release from pulmonary artery smooth muscle cells in vitro (Asbtract). Circulation 1991;84(suppl II):92
32. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161: 1220-7
33. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-9
34. Murphy JD, Vawter GF, Reid LN. Pulmonary vascular disease in fatal meconium aspiration. J Pediatr 1984;104:758-62
35. Vierhapper H, Wagner O, Nowotny P, Waldhausl W. Effect of endothelin-1 in man. Circulation 1990;81:1415-8
36. Bloch KD, Friedrich SP, Lee ME. et al. Structural organization and chromosome assignment of the gene encoding endothelin. J Biol Chem 1989;264:10851-7
37. Deleuze PH, Adnot S, Shiiya N, et al. Endothelin dilates bovine pulmonary circulation and reverses hypoxic pulmonary vasoconstriction. J Cardiovasc Pharmacol 1992; 19:354-60
38. DeNucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-800
39. Warner TD, Mitchell JA, de Nucci G, Vare JR. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 1989;13(suppl 5):S85-8
40. Lippton HL, Cohen GA, McMurtry IF, Hyman AL. Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J Appl Physiol 1991;70:947-52
41. Sirvio ML, Metsarinne K, Saijonmaa O, Fyhrquist F. Tissue distribution and half life of 1251-endothelin in the rat: Importance of pulmonary clearance. Biochem Biophys Res Commun 1990;167:1191-5
42. Westcott JY, Henson J, McMurtry IF, O'Brien RF. Uptake and metabolism of endothelin in the isolated perfused rat lung. Exp Lung Res 1990;16:521-32